CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 26 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $35,000 | -22.2% | 90,700 | 0.0% | 0.00% | – |
| Q4 2015 | $45,000 | -2.2% | 90,700 | 0.0% | 0.00% | – |
| Q3 2015 | $46,000 | -37.0% | 90,700 | 0.0% | 0.00% | – |
| Q2 2015 | $73,000 | +30.4% | 90,700 | 0.0% | 0.00% | – |
| Q1 2015 | $56,000 | 0.0% | 90,700 | 0.0% | 0.00% | – |
| Q4 2014 | $56,000 | -79.7% | 90,700 | 0.0% | 0.00% | – |
| Q3 2014 | $276,000 | -0.7% | 90,700 | 0.0% | 0.00% | – |
| Q2 2014 | $278,000 | +858.6% | 90,700 | +1195.7% | 0.00% | – |
| Q4 2013 | $29,000 | -3.3% | 7,000 | 0.0% | 0.00% | – |
| Q3 2013 | $30,000 | +42.9% | 7,000 | 0.0% | 0.00% | – |
| Q2 2013 | $21,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 250,000 | $920,000 | 0.42% |
| Rotella Capital Management, Inc. | 19,639 | $72,000 | 0.09% |
| Invesco Private Capital | 116,316 | $428,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 26,500 | $97,000 | 0.01% |
| Allianz Asset Management GmbH | 559,207 | $2,058,000 | 0.00% |
| North Star Investment Management Corp. | 1,857 | $7,000 | 0.00% |
| UBS AG | 1,000 | $4,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 4,300 | $16,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 26,712 | $98,000 | 0.00% |
| NORTHERN TRUST CORP | 32,991 | $121,000 | 0.00% |